fbpx
Select Page

Who is Assessing YOUR Vax Autoimmune Risk Profile?

May 25, 2024 | COVID-19, Research, Treatment

Assessing the Risk of Autoimmunity from Vaccination

  • Autoimmunity risk from vaccination is a concern due to the spike protein’s role in triggering the immune system. • 0:00

  • Companies mandating vaccines should assess and control potential risks at a population level. • 1:30

  • The spike protein of the SARS-CoV-2 virus plays a critical role in infection and potential autoimmune responses. • 2:49

  • There is a 46% relative risk increase of autoimmunity with COVID-19 infection, indicating its association with the spike protein. • 4:08

Assessing potential autoimmune risks from spike protein exposure in vaccination and infection.

  • Proteins binding to spike protein may trigger autoimmune response. • 4:45

  • Failure to acknowledge potential risks is a health and safety concern. • 7:07

  • Impaired mucosal immunity could increase autoimmune risk. • 8:41

Assessing the potential autoimmune risk profile from ongoing exposure to spike protein in vaccinated individuals.

  • Identification of high-risk cohorts with health comorbidities and recurrent infections. • 9:15

  • Importance of considering potential risks and addressing autoimmune response triggered by spike protein. • 12:27

  • Need for reflection on challenges ahead and asking important questions in public health. • 13:05